Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population‐based study

Jiang Zhu,Chang Liu,Hui Li,Haoyu Ren,Yunshi Cai,Tian Lan,Hong Wu
DOI: https://doi.org/10.1002/cam4.5620
IF: 4.711
2023-01-18
Cancer Medicine
Abstract:Regarding ICC, the eighth edition of the American Joint Committee on Cancer (AJCC) staging system simply classified the N stage as N0 and N1 on the basis of LN status. The implications of lymph node dissection (LND) and the prognostic impact of the number of lymph node metastases on survival in intrahepatic cholangiocarcinoma (ICC) remain unclear. By analyzing a large cohort of more than 1000 resected ICC patients, the present study showed that despite the lack of a clear survival benefit of LND in patients with ICC, a Significant positive association between the number of LNM and poor outcomes was observed. We still suggest adequate LND by examining at least 6 lymph nodes to ensure precise staging. On this basis, the recently proposed nodal classification of N0, N1, and N2 stages may also allow better prognostic stratification of ICC patients. Purpose To comprehensively investigate the implications of lymph node dissection (LND) and the prognostic impact of the number of lymph node (LN) metastases on survival in intrahepatic cholangiocarcinoma (ICC) using a large‐scale study. Methods Patients who underwent surgical resection for ICC between 2004 and 2018 were identified from the Surveillance, Epidemiology, and End Results (SEER) registries. The Kaplan–Meier and log‐rank tests were used to compare cancer‐specific survival (CSS) and overall survival (OS) between different groups. Propensity score matching (PSM) and subgroup analyses were performed to balance potential confounding factors. A multivariate Cox proportional hazards regression model was used to identify prognostic factors of survival outcomes. Restricted cubic splines fitted in the Cox proportional hazard regression models were also conducted to examine associations between continuous variables and outcomes. Results In all, 1028 patients were enrolled. There were 652 (63.4%) patients undergoing LND, with lymph node metastasis (LNM) confirmed in 212 (32.5%) cases. Patients receiving LND did not show better survival outcomes than those receiving non‐LND (NLND). We divided the LND group into two subgroups: patients with LNM (+) and those without LNM (−). Among these three groups, patients with LNM experienced the worst CSS and OS, while NLND patients had similar survival times to LNM (−) patients. Restricted cubic spline analysis indicated that an increased number of LNM was associated with a decreased chance of survival (p
oncology
What problem does this paper attempt to address?